Your browser does not support scripts, this page will not display properly!
ISMP (US)
Contact Us
Feedback
Search:
ISMP Canada News
December 2, 2019:
Health Canada: Important Safety Update on XELJANZ / XELJANZ XR (tofacitinib) – Risk of Thrombosis
Health Canada: Important Safety Update on XELJANZ / XELJANZ XR (tofacitinib) – Risk of Thrombosis" trackback:ping="https://www.ismp-canada.org/news/bblog/trackback.php/406/" />
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved.